IRCT20210602051472N1尚未招募2 期
Evaluation of the Edaravan Effect on the outcomes and oxidative stress parameters in patients with acute ischemic stroke: a clinical trial study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Focal neurological symptoms due to cerebrovascular involvement in less than 24 hours
- •Older age 18 years
- •Stroke is approved by CT or MRI.
- •The severity of the stroke should be greater than 4 by the NIHSS criteria and the patient's ability scale before the stroke should be less than 2. It should be noted that it is also injected at intensities higher than 24.
- •The patient is inclined to enter the study
排除标准
- •Hemorrhagic stroke
- •Transient stroke
- •Brain Tumor
- •Inflammatory diseases and demyelinating brain
- •History of craniotomy
- •Previous severe brain trauma
- •Liver and kidney failure
- •Pregnancy and lactation
- •Acute heart attack
- •Allergy to the drug Adaravan
研究者
相似试验
尚未招募
3 期
Effectivnes of edaravone on ischemic strokeIschemic stroke.Cerebral infarctionIRCT20240224061102N1Yasouj University of Medical Sciences60
尚未招募
Unknown
Evaluation of Ayurvedic Management Through Erandmuladi Basti and Shwet Aparajita Churna in Hypothyroidism.CTRI/2023/04/051564Pt Khushilal Sharma Government(Autonomous) College and Institute, Bhopal
已完成
2 期
Evaluation of the occurrence, effect and side effects oFcyclophosfamid and rituximab in the tratment of children with NEPHROTIC SYNDROM resistance to STEROID that referred to Hazrate Massumeh hospital .IRCT20170527034146N2Ghoum University of Medical Sciences102
已完成
不适用
The examination of the efficacy by adverse reaction changing the treatment with Oxybutynin or Mirabegron on the patient who cannot go on treatment with anticholinergic agentJPRN-UMIN000019736Department of Urology, Shiga University of medical science15
尚未招募
2 期
A Study to compare the effect of Erandmooladi enema therapy with sand sudation and Erandmooladi enema therapy with Oral medicine in the Management of Rheumatoid arthritisCTRI/2023/04/051961Dr Daljit Kaur